AI has possible applications in all aspects of new drug R&D with the potential to reduce the times and costs associated with bringing new treatments to market. 

Writing in the journal, Engineering , authors say that the explosive growth of biomedical data, coupled with AI, has led to a revolution in drug R&D. In their review, the authors discuss specific AI applications in various stages of drug R&D.

Although the authors conclude that AI can greatly reduce the cycle time and cost of drug R&D,  limitations remain in the AI-based drug R&D process. They note that AI is helping scientists unravel the mystery of large and complex biological systems.